FDA Inspection 590180 — Aventis Pharma Ltd.

Aventis Pharma Ltd. — FEI 1000541557

The FDA completed an inspection of Aventis Pharma Ltd. on May 1, 2009 in Dagenham. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
May 1, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dagenham (United Kingdom)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.